Free Trial

Acurx Pharmaceuticals (ACXP) SEC Filings & 10K Form

Acurx Pharmaceuticals logo
$0.88 +0.10 (+12.20%)
As of 01/17/2025 04:00 PM Eastern

Recent Acurx Pharmaceuticals SEC Filings

DateFilerForm TypeView
01/17/2025
4:11 PM
Acurx Pharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
01/08/2025
3:31 PM
Acurx Pharmaceuticals (Issuer)
LUCI DAVID P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
3:31 PM
Acurx Pharmaceuticals (Issuer)
Sailer Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
3:32 PM
Acurx Pharmaceuticals (Issuer)
Scodari Joseph C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
3:30 PM
Acurx Pharmaceuticals (Issuer)
DEAN JACK H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
3:30 PM
Acurx Pharmaceuticals (Issuer)
DELUCCIA ROBERT J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
3:31 PM
Acurx Pharmaceuticals (Issuer)
Donohue James J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
9:00 AM
Acurx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2025
9:03 AM
Acurx Pharmaceuticals (Filer)
Form 424B5
01/06/2025
2:51 PM
Acurx Pharmaceuticals (Filer)
Form 424B3
11/13/2024
6:06 AM
Acurx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2024
6:13 AM
Acurx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
6:13 AM
Acurx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
3:05 PM
Acurx Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/03/2024
8:55 PM
Acurx Pharmaceuticals (Issuer)
DELUCCIA ROBERT J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
8:56 PM
Acurx Pharmaceuticals (Issuer)
Shawah Robert G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
8:56 PM
Acurx Pharmaceuticals (Issuer)
LUCI DAVID P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
6:31 AM
Acurx Pharmaceuticals (Subject)
Form FWP
03/29/2024
3:58 PM
Acurx Pharmaceuticals (Filer)
Form S-1/A
03/15/2024
3:33 PM
Acurx Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/14/2024
1:39 PM
Acurx Pharmaceuticals (Subject)
ARMISTICE CAPITAL, LLC (Filed by)
Form SC 13G/A
01/22/2024
5:15 AM
Acurx Pharmaceuticals (Issuer)
Sailer Carl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ACXP) was last updated on 1/20/2025 by MarketBeat.com Staff
From Our Partners